CG FV (Femara 2.5 mg)

Generic Name: letrozole

Pill with imprint CG FV is Yellow, Round and has been identified as Femara 2.5 mg. It is supplied by Novartis Pharmaceuticals.

Femara is used in the treatment of breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Femara 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CG FV

Femara

Generic Name

letrozole

Imprint

CG FV

Strength

2.5 mg

Color

Yellow

Size

7.00 mm

Shape

Round

Availability

Prescription only

Drug Class

Aromatase inhibitors, Hormones/antineoplastics

Pregnancy Category

D - Positive evidence of risk

CSA Schedule

Not a controlled drug

Labeler / Supplier

Novartis Pharmaceuticals

Inactive Ingredients

silicon dioxide, ferric oxide yellow, hypromelloses, lactose monohydrate, magnesium stearate, corn starch, microcrystalline cellulose, polyethylene glycol, sodium starch glycolate type A potato, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00078-0249	Novartis Pharmaceuticals Corporation
54868-4151	Physicians Total Care Inc. (repackager)
54569-5714	A-S Medication Solutions, LLC (repackager)
35356-0409	Lake Erie Medical and Surgical Supply (repackager)

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer